Sutro Biopharma (STRO) Times Interest Earned (2017 - 2022)
Sutro Biopharma recorded quarterly Times Interest Earned of -$7.61 in Q3 2022, up 76.68% quarter-over-quarter from -$32.62 in Q2 2022, and up 82.01% year-over-year from -$4.18 in Q3 2021.
Sutro Biopharma's Times Interest Earned history runs 6 years deep, the most recent figure standing at -$7.61 for Q3 2022.
- In Q3 2022, Times Interest Earned rose 82.01% year-over-year to -$7.61; the TTM figure through Jun 2023 stood at -$56.98 (down 19.22% YoY), while the FY2021 annual figure was -$31.41, down 80.2% from the prior year.
- Times Interest Earned came in at -$7.61 for Q3 2022 at Sutro Biopharma, up from -$32.62 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $23.84 in Q2 2018 to a low of -$59.56 in Q1 2022.
- A 5-year average of -$17.14 and a median of -$12.3 in 2019 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned soared 161.0% in 2020 and tumbled 822.81% in 2021, its largest moves.
- Sutro Biopharma's Times Interest Earned stood at $5.05 in 2018, then tumbled by 458.55% to -$18.09 in 2019, then surged by 161.0% to $11.04 in 2020, then slumped by 618.72% to -$57.25 in 2021, then soared by 86.71% to -$7.61 in 2022.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$7.61, -$32.62, and -$59.56 for Q3 2022, Q2 2022, and Q1 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -7.61 |
| Jun 30, 2022 | -32.62 |
| Mar 31, 2022 | -59.56 |
| Dec 31, 2021 | -57.25 |
| Sep 30, 2021 | -42.29 |
| Jun 30, 2021 | -11.58 |
| Mar 31, 2021 | -22.16 |
| Dec 31, 2020 | 11.04 |
| Sep 30, 2020 | -4.58 |
| Jun 30, 2020 | -5.56 |
| Mar 31, 2020 | -18.16 |
| Dec 31, 2019 | -18.09 |
| Sep 30, 2019 | -11.16 |
| Jun 30, 2019 | -11.11 |
| Mar 31, 2019 | -12.30 |
| Dec 31, 2018 | 5.05 |
| Sep 30, 2018 | -21.03 |
| Jun 30, 2018 | 23.84 |
| Mar 31, 2018 | -30.56 |
| Dec 31, 2017 | -40.23 |
| Sep 30, 2017 | -4.53 |